Figure 2.
Variation trends of breast density, endometrial thickness, estradiol (E2), and lipidemia. Note: Group (A), geserelin plus tamoxifen; group (B), tamoxifen alone. (A), E2; (B), breast density; (C), endometrial thickness; (D), triglycerides (TG); (E), Chol, cholesterol; (F), low-density lipoprotein (LDL); (G), high-density lipoprotein (HDL).
